Marshall Wace LLP Cuts Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Marshall Wace LLP reduced its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 59.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,476 shares of the medical instruments supplier’s stock after selling 5,080 shares during the quarter. Marshall Wace LLP owned 0.06% of Mesa Laboratories worth $458,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in MLAB. Amundi boosted its position in Mesa Laboratories by 81.6% during the 4th quarter. Amundi now owns 661 shares of the medical instruments supplier’s stock worth $91,000 after purchasing an additional 297 shares during the period. Resona Asset Management Co. Ltd. acquired a new stake in shares of Mesa Laboratories in the fourth quarter valued at about $92,000. KLP Kapitalforvaltning AS purchased a new stake in shares of Mesa Laboratories during the 4th quarter valued at about $132,000. Berry Wealth Group LP lifted its position in Mesa Laboratories by 5.3% during the 4th quarter. Berry Wealth Group LP now owns 1,657 shares of the medical instruments supplier’s stock worth $219,000 after acquiring an additional 83 shares in the last quarter. Finally, Pacer Advisors Inc. boosted its holdings in Mesa Laboratories by 4.3% in the 4th quarter. Pacer Advisors Inc. now owns 1,755 shares of the medical instruments supplier’s stock worth $231,000 after acquiring an additional 73 shares during the period. Institutional investors and hedge funds own 90.60% of the company’s stock.

Insider Buying and Selling

In other news, CEO Gary M. Owens sold 21,000 shares of the business’s stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $123.91, for a total value of $2,602,110.00. Following the completion of the sale, the chief executive officer now owns 43,337 shares of the company’s stock, valued at approximately $5,369,887.67. The trade was a 32.64 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 4.40% of the company’s stock.

Mesa Laboratories Trading Up 3.2 %

MLAB opened at $119.06 on Friday. The firm has a market capitalization of $646.97 million, a P/E ratio of -2.57 and a beta of 0.97. The firm’s 50 day moving average is $120.91 and its 200-day moving average is $126.74. The company has a quick ratio of 0.53, a current ratio of 0.71 and a debt-to-equity ratio of 0.61. Mesa Laboratories, Inc. has a 52-week low of $83.68 and a 52-week high of $155.12.

Mesa Laboratories (NASDAQ:MLAB) last posted its quarterly earnings data on Tuesday, February 4th. The medical instruments supplier reported $2.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.66. Mesa Laboratories had a negative net margin of 104.92% and a positive return on equity of 30.23%. Analysts expect that Mesa Laboratories, Inc. will post 8 EPS for the current fiscal year.

Mesa Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Friday, May 30th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.54%. The ex-dividend date of this dividend is Friday, May 30th. Mesa Laboratories’s payout ratio is currently -1.38%.

Mesa Laboratories Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.